Aurobindo Pharma receives approval for Terbinafine Tablets
By TMI | December 24, 2008
Aurobindo Pharma Ltd has informed BSE regarding a Press Release dated December 24, 2008 titled “Aurobindo Pharma receives approval for Terbinafine Tablets from Health Canada”. They also have quoted that this drug has got approval for 125 mg and 250 mg tablets which are mainly used for the fungal infections of skin and nails.
The stock has reacted quite very nicelyand is currently trading nearly 4% up at 155.28 Rs.
Topics: Buzzing Stocks |
« GEE fixes Record Date for Bonus Shares | Home | Fortis Healthcare Board approves Rights Issue »